Aloe Blacc’s fame means nothing in biotech (and that’s the point)

What Happened

Grammy-nominated singer Aloe Blacc is developing a cancer drug platform targeting pancreatic cancer after experiencing COVID despite vaccination. He discovered biotech requires regulatory compliance and commercialization plans, not just funding. He is bootstrapping research and delaying investor outreach until peer-reviewed papers validate his work. Pancreatic cancer kills ninety percent of patients.

Key Entities

AI Tools